162 related articles for article (PubMed ID: 34921102)
1. Association of Serum Neurofilament Light Chain Concentration and MRI Findings in Older Adults: The Cardiovascular Health Study.
Fohner AE; Bartz TM; Tracy RP; Adams HHH; Bis JC; Djousse L; Satizabal CL; Lopez OL; Seshadri S; Mukamal KJ; Kuller LH; Psaty BM; Longstreth WT
Neurology; 2022 Mar; 98(9):e903-e911. PubMed ID: 34921102
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol Variability and Cranial Magnetic Resonance Imaging Findings in Older Adults: The Cardiovascular Health Study.
Kalani R; Bartz TM; Suchy-Dicey A; Elkind MSV; Psaty BM; Leung LY; Rice K; Tirschwell D; Longstreth WT
Stroke; 2020 Jan; 51(1):69-74. PubMed ID: 31842691
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage.
Meeker KL; Butt OH; Gordon BA; Fagan AM; Schindler SE; Morris JC; Benzinger TLS; Ances BM
Neurobiol Dis; 2022 May; 166():105662. PubMed ID: 35167933
[TBL] [Abstract][Full Text] [Related]
4. Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke.
Peng Y; Li Q; Qin L; He Y; Luo X; Lan Y; Chen X; Wang X; Wang QM
Neurorehabil Neural Repair; 2021 Mar; 35(3):247-255. PubMed ID: 33522401
[TBL] [Abstract][Full Text] [Related]
5. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
[TBL] [Abstract][Full Text] [Related]
6. Lower White Matter Volume and Worse Executive Functioning Reflected in Higher Levels of Plasma GFAP among Older Adults with and Without Cognitive Impairment.
Asken BM; VandeVrede L; Rojas JC; Fonseca C; Staffaroni AM; Elahi FM; Lindbergh CA; Apple AC; You M; Weiner-Light S; Brathaban N; Fernandes N; Boxer AL; Miller BL; Rosen HJ; Kramer JH; Casaletto KB
J Int Neuropsychol Soc; 2022 Jul; 28(6):588-599. PubMed ID: 34158138
[TBL] [Abstract][Full Text] [Related]
7. Plasma Neurofilament Light and Longitudinal Progression of White Matter Hyperintensity in Elderly Persons Without Dementia.
Sun Y; Tan L; Xu W; Wang ZT; Hu H; Li JQ; Dong Q; Tan L; Yu JT;
J Alzheimers Dis; 2020; 75(3):729-737. PubMed ID: 32310173
[TBL] [Abstract][Full Text] [Related]
8. Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik Study.
van Gennip ACE; Satizabal CL; Tracy RP; Sigurdsson S; Gudnason V; Launer LJ; van Sloten TT
Geroscience; 2024 Feb; 46(1):505-516. PubMed ID: 37530894
[TBL] [Abstract][Full Text] [Related]
9. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
[TBL] [Abstract][Full Text] [Related]
10. Serum total tau, neurofilament light, and glial fibrillary acidic protein are associated with mortality in a population study.
Halloway S; Evans DA; Desai P; Dhana K; Beck T; Rajan KB
J Am Geriatr Soc; 2024 Jan; 72(1):149-159. PubMed ID: 37818793
[TBL] [Abstract][Full Text] [Related]
11. White matter hyperintensity, neurofilament light chain, and cognitive decline.
Dhana A; DeCarli C; Dhana K; Desai P; Wilson RS; Evans DA; Rajan KB
Ann Clin Transl Neurol; 2023 Mar; 10(3):321-327. PubMed ID: 36542548
[TBL] [Abstract][Full Text] [Related]
12. Circulating sphingolipids and subclinical brain pathology: the cardiovascular health study.
Moseholm KF; Horn JW; Fitzpatrick AL; Djoussé L; Longstreth WT; Lopez OL; Hoofnagle AN; Jensen MK; Lemaitre RN; Mukamal KJ
Front Neurol; 2024; 15():1385623. PubMed ID: 38765262
[TBL] [Abstract][Full Text] [Related]
13. Atypical White Matter Hyperintensities Markedly Impact Plasma Neurofilament Light Chain Variability in GRN Patients.
Vítor J; Saracino D; Ströer S; Camuzat A; Dorgham K; Clot F; Martin-Hardy P; Pasquier F; ; Le Ber I
J Alzheimers Dis; 2023; 94(4):1351-1360. PubMed ID: 37393503
[TBL] [Abstract][Full Text] [Related]
14. Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study.
Cronjé HT; Liu X; Odden MC; Moseholm KF; Seshadri S; Satizabal CL; Lopez OL; Bis JC; Djoussé L; Fohner AE; Psaty BM; Tracy RP; Longstreth WT; Jensen MK; Mukamal KJ
Alzheimers Dement; 2023 Dec; 19(12):5672-5680. PubMed ID: 37392405
[TBL] [Abstract][Full Text] [Related]
15. Association of Plasma Neurofilament Light With Small Vessel Disease Burden in Nondemented Elderly: A Longitudinal Study.
Qu Y; Tan CC; Shen XN; Li HQ; Cui M; Tan L; Dong Q; Yu JT;
Stroke; 2021 Mar; 52(3):896-904. PubMed ID: 33517704
[TBL] [Abstract][Full Text] [Related]
16. Association of MRI Visible Perivascular Spaces and Neurofilament Light Chain: The Framingham Heart Study.
Ekenze O; Pinheiro A; Demissie S; Aparicio HJ; Charidimou A; Beiser AS; Satizabal CL; Kautz T; DeCarli C; Greenberg S; Seshadri S; Romero JR
J Alzheimers Dis; 2023; 95(3):1133-1145. PubMed ID: 37661877
[TBL] [Abstract][Full Text] [Related]
17. Glial fibrillary acidic protein elevations relate to neuroimaging abnormalities after mild TBI.
Gill J; Latour L; Diaz-Arrastia R; Motamedi V; Turtzo C; Shahim P; Mondello S; DeVoto C; Veras E; Hanlon D; Song L; Jeromin A
Neurology; 2018 Oct; 91(15):e1385-e1389. PubMed ID: 30209234
[TBL] [Abstract][Full Text] [Related]
18. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline.
Dark HE; An Y; Duggan MR; Joynes C; Davatzikos C; Erus G; Lewis A; Moghekar AR; Resnick SM; Walker KA
Alzheimers Res Ther; 2024 Apr; 16(1):94. PubMed ID: 38689358
[TBL] [Abstract][Full Text] [Related]
20. Serum Tau, Neurofilament Light Chain, Glial Fibrillary Acidic Protein, and Ubiquitin Carboxyl-Terminal Hydrolase L1 Are Associated with the Chronic Deterioration of Neurobehavioral Symptoms after Traumatic Brain Injury.
Lange RT; Lippa S; Brickell TA; Gill J; French LM
J Neurotrauma; 2023 Mar; 40(5-6):482-492. PubMed ID: 36170576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]